MétaCan
Menu
Back to cohort
Record W4221088306 · doi:10.5694/mja2.51479

Effectiveness of <scp>COVID</scp> ‐19 vaccines: findings from real‐world studies

2022· letter· en· W4221088306 on OpenAlexaboutno aff
David Henry, Mark Jones, Paulina Stehlik, Paul Glasziou

Bibliographic record

VenueThe Medical Journal of Australia · 2022
Typeletter
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineVaccinationCoronavirus disease 2019 (COVID-19)ConfoundingPublic healthSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Family medicineEnvironmental healthDemographyDiseaseInfectious disease (medical specialty)Virology

Abstract

fetched live from OpenAlex

To the Editor: We recently reviewed the first studies of the real-world effectiveness of coronavirus disease 2019 (COVID-19) vaccines.1 We found evidence of protection against serious illness and death but noted the difficulties in performing such studies in Australia. This was because of the (then) low national case numbers and lack of ready access to the necessary linked health data. Since then, the literature on vaccine effectiveness has expanded dramatically. By February 2022 the Johns Hopkins Bloomberg School of Public Health and partners had generated a database of 181 studies conducted in 26 countries.2 The most studied vaccines were Pfizer (117 studies), Moderna (47), AstraZeneca (43), Janssen (17) and Sinovac (8). Twenty-three studies investigated booster doses, and seven studies mentioned analysis of the Omicron variant. Study outcomes included infections (117 studies), hospitalisations (69), deaths (30), and viral transmission (5). Study designs varied, with 32 mentioning cohort analysis and 16 mentioning test negative analysis in their titles. Most studies were performed in the United States (56 studies), followed by Israel (32), the United Kingdom (29), Qatar (9), Canada (8), Brazil (6) and Denmark (4). Not one of the listed studies was conducted in Australia. We should be asking why. Australia no longer lacks the case numbers to make estimates of vaccine effectiveness. We collect good data on vaccination status, infections (including viral variants), hospitalisations and deaths, plus the information needed to adjust for confounding of the associations between vaccine exposure and outcomes. However, authorities have not linked these datasets at individual level and made them available for detailed analysis. This situation should not continue. There are well established principles for protecting the privacy of individuals who are included in routinely collected data.3 The Commonwealth and state governments and relevant agencies seem unable or unwilling to link and properly analyse these data. Consequently, they should ensure that regularly updated comprehensively linked de-identified datasets can be accessed by qualified researchers. Stephen Duckett has recently called for an Australian review of lessons from the COVID-19 pandemic using a systems rather than a punitive lens.4 We agree. Better linkage, access and analysis of our health system data should be high on the list. No relevant disclosures.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.008
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.719
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0060.008
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0020.000
Research integrity0.0010.008
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.095
GPT teacher head0.414
Teacher spread0.320 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueThe Medical Journal of AustraliaSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207